Viagenpumatucel-L (HS-110)

Viagenpumatucel-L · Heat Biologics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Viagenpumatucel-L (HS-110), covering 2020-02-05 to 2023-09-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer [Phase 1, Phase 2]

See pricing